Aprea Therapeutics, Inc. (APRE) stock
APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46+0.01 (+2.60%)
Close on Nov 18, 2026Market cap $5.85MP/E –Yield –
Aprea Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Aprea Therapeutics's price to book ratio was 0.1× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 1.9×, with a median of 0.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −0.3 |
| 2025 | Dec 31, 2025 | 0.5× | −0.3 |
| 2024 | Dec 31, 2024 | 0.8× | −0.1 |
| 2023 | Dec 29, 2023 | 0.9× | +0.2 |
| 2022 | Dec 30, 2022 | 0.6× | −0.5 |
| 2021 | Dec 31, 2021 | 1.1× | −0.0 |
| 2020 | Dec 31, 2020 | 1.2× | – |
See a number that looks wrong?